Zhuo Wang

Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma.

J. Que, Yaxin Yang, M. Jiang, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Aberrantly Expressed Genes and miRNAs in Slow Transit Constipation Based on RNA-Seq Analysis

Bin Kong, Qiang Chen, Shipeng Zhao, 2018, BioMed research international.

SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p

Yaxin Yang, Kuancan Liu, T. Zhao, 2022, Cancer biology & therapy.

The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy

Yaxin Yang, Kuancan Liu, T. Zhao, 2021, Biomarker research.

The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer

Qiang Chen, Shipeng Zhao, Zhuo Wang, 2016, Medicine.

The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.

Kuancan Liu, Shihui Zhang, Yijian Zhou, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

HPV16 infection promotes the malignant transformation of the esophagus and progression of esophageal squamous cell carcinoma

Kuancan Liu, Liming Tian, Shihui Zhang, 2023, Journal of medical virology.

Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma

Kuancan Liu, T. Zhao, Shihui Zhang, 2023, Cell death discovery.

Agaricus blazei murrill and Enteromorpha prolifera-derived polysaccharides gain therapeutic effects on esophageal squamous cell carcinoma

Kuancan Liu, Penghu Liu, Shihui Zhang, 2024, Journal of Functional Foods.